Hamlet BioPharma
@hamletbiopharma.com
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections. Digital Events News ... Subscribe to our Press releases and Newsletters All Posts Recent Posts Pressrelease – Lund, June 29th, 2026 – Hamlet BioPharma Receives European Regulatory Approval for Phase III Study of Alpha1H in Bladder […]
Hamlet BioPharma's Company Logos
Hamlet BioPharma's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1A5F93
Matisse
26, 95, 147
206, 70, 34
82, 35, 0, 42
#FF339E
Wild Strawberry
255, 51, 158
329, 100, 60
0, 80, 38, 0
#5F0087
Pigment Indigo
95, 0, 135
282, 100, 26
30, 100, 0, 47
About Hamlet BioPharma
Hamlet BioPharma is a pharmaceutical company operating in the field of medicine development. The company specializes in developing medicines based on a tumor-killing protein-lipid complex formed by two natural and harmless molecules found in breast milk. Their focus is on creating products primarily for the treatment and prevention of cancer diseases.
Current studies are being conducted on cases involving bladder cancer, with plans to expand operations to include other forms of cancer. Hamlet BioPharma has a strong portfolio of projects aimed at treating cancer and infections. With ongoing clinical trials and a commitment to innovation, they are at the forefront of developing groundbreaking treatments.
Stay updated on their progress as they strive to make a significant impact in the medical field
Company type
Public Company
Year founded
2015
Company size
2-10 employees
